Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272

1.

Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries.

Hjort M, Eggers KM, Lindhagen L, Agewall S, Brolin EB, Collste O, Daniel M, Ekenbäck C, Frick M, Henareh L, Hofman-Bang C, Malmqvist K, Spaak J, Sörensson P, Y-Hassan S, Tornvall P, Lindahl B.

Clin Chem. 2019 May 9. pii: clinchem.2018.301085. doi: 10.1373/clinchem.2018.301085. [Epub ahead of print]

PMID:
31072836
2.

ST-segment elevation and cardiac magnetic resonance imaging findings in myocardial infarction with non-obstructive coronary arteries.

Hausvater A, Pasupathy S, Tornvall P, Gandhi H, Tavella R, Beltrame J, Agewall S, Ekenbäck C, Brolin EB, Hochman JS, Collste O, Reynolds HR.

Int J Cardiol. 2019 Jul 15;287:128-131. doi: 10.1016/j.ijcard.2019.04.028. Epub 2019 Apr 10.

PMID:
31003795
3.

Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association.

Tamis-Holland JE, Jneid H, Reynolds HR, Agewall S, Brilakis ES, Brown TM, Lerman A, Cushman M, Kumbhani DJ, Arslanian-Engoren C, Bolger AF, Beltrame JF; American Heart Association Interventional Cardiovascular Care Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research.

Circulation. 2019 Apr 30;139(18):e891-e908. doi: 10.1161/CIR.0000000000000670.

PMID:
30913893
4.

European Heart Journal - Cardiovascular Pharmacotherapy: now accepted for an official Impact Factor.

Agewall S.

Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):59. doi: 10.1093/ehjcvp/pvz009. No abstract available.

PMID:
30874813
5.

Unsolved issues in oral anticoagulation treatment in atrial fibrillation.

Agewall S.

Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):60-61. doi: 10.1093/ehjcvp/pvz008. No abstract available.

PMID:
30874812
6.

Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate.

Rosano GMC, Spoletini I, Agewall S.

Eur Heart J Suppl. 2019 Feb;21(Suppl A):A28-A33. doi: 10.1093/eurheartj/suy035. Epub 2019 Feb 26.

7.

Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.

Täger T, Fröhlich H, Grundtvig M, Seiz M, Schellberg D, Goode K, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Clark AL, Frankenstein L.

Int J Cardiol. 2019 Feb 2. pii: S0167-5273(18)36011-X. doi: 10.1016/j.ijcard.2019.01.109. [Epub ahead of print]

PMID:
30827731
8.

Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe.

Fröhlich H, Rosenfeld N, Täger T, Goode K, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Clark AL, Frankenstein L, Grundtvig M.

Heart. 2019 Feb 21. pii: heartjnl-2018-314256. doi: 10.1136/heartjnl-2018-314256. [Epub ahead of print]

PMID:
30792238
9.

EHJ Cardiovascular Pharmacotherapy has Impact Factor.

Agewall S.

Eur Heart J. 2019 Feb 14;40(7):572. doi: 10.1093/eurheartj/ehy897. No abstract available.

PMID:
30768210
10.

Medical Misinformation: Vet the Message!

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C.

J Cardiovasc Pharmacol. 2019 Feb;73(2):61-62. doi: 10.1097/FJC.0000000000000648. No abstract available.

PMID:
30730472
11.

Ivabradine for heart failure: regulatory differences in Europe and United States.

Marciniak TA, Hall TS, Atar D, Agewall S, Serebruany VL.

Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):119-121. doi: 10.1093/ehjcvp/pvz006. No abstract available.

PMID:
30715322
12.

Medical misinformation: Vet the message!

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C.

Heart Rhythm. 2019 Mar;16(3):332-333. doi: 10.1016/j.hrthm.2018.12.030. Epub 2019 Jan 28. No abstract available.

13.

Medical Misinformation: Vet the Message!

Hill JA; following HEART Group Signatories, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C.

Eur Heart J. 2019 Feb 1;40(5):404-405. doi: 10.1093/eurheartj/ehz009. No abstract available.

14.

Medical misinformation: vet the message!

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C.

Eur Heart J Qual Care Clin Outcomes. 2019 Apr 1;5(2):83-84. doi: 10.1093/ehjqcco/qcy057. No abstract available.

15.

Medical misinformation: vet the message!

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C.

Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):62-63. doi: 10.1093/ehjcvp/pvz001. No abstract available.

16.

Medical misinformation: vet the message!

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C.

Cardiovasc Res. 2019 Jan 28. doi: 10.1093/cvr/cvz007. [Epub ahead of print] No abstract available.

PMID:
30689762
17.

Medical Misinformation.

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C.

Circulation. 2019 Jan 29;139(5):571-572. doi: 10.1161/CIRCULATIONAHA.118.039193. No abstract available.

PMID:
30689419
18.

Medical Misinformation: Vet the Message!

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol C, Grines C, Gropler RJ, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis AD, Vrints CJ.

Circulation. 2019 Jan 28. doi: 10.1161/CIRCULATIONAHA.118.039193. [Epub ahead of print] No abstract available.

PMID:
30688522
19.

Medical Misinformation.

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C.

Circ Cardiovasc Interv. 2019 Feb;12(2):e007796. doi: 10.1161/CIRCINTERVENTIONS.119.007796. No abstract available.

PMID:
30688520
20.

Medical Misinformation.

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol C, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C; All authors are HEART Group Signatories.

Circ Cardiovasc Qual Outcomes. 2019 Feb;12(2):e005496. doi: 10.1161/CIRCOUTCOMES.119.005496. No abstract available.

PMID:
30688519
21.

Medical Misinformation.

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C.

Circ Cardiovasc Imaging. 2019 Feb;12(2):e008809. doi: 10.1161/CIRCIMAGING.118.008809. No abstract available.

PMID:
30688516
22.

Medical Misinformation.

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C.

Circ Genom Precis Med. 2019 Feb;12(2):e002439. doi: 10.1161/CIRCGEN.118.002439. No abstract available.

PMID:
30688515
23.

Medical Misinformation.

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C; All authors are HEART Group Signatories.

Circ Heart Fail. 2019 Feb;12(2):e005869. doi: 10.1161/CIRCHEARTFAILURE.119.005869. No abstract available.

PMID:
30688079
24.

Medical Misinformation.

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C.

Hypertension. 2019 Mar;73(3):506-507. doi: 10.1161/HYPERTENSIONAHA.118.12518. No abstract available.

PMID:
30686083
25.

Old and new drugs in cardiovascular pharmacotherapy.

Agewall S.

Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):1-2. doi: 10.1093/ehjcvp/pvy046. No abstract available.

PMID:
30615170
26.

Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries.

Nero D, Agewall S, Daniel M, Caidahl K, Collste O, Ekenbäck C, Frick M, Henareh L, Jernberg T, Malmqvist K, Schenck-Gustafsson K, Spaak J, Sörensson P, Sundin Ö, Y-Hassan S, Hofman-Bang C, Tornvall P.

Am J Med. 2019 Mar;132(3):374-381.e1. doi: 10.1016/j.amjmed.2018.11.010. Epub 2018 Nov 30.

PMID:
30503881
27.

Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review.

Navarese EP, Andreotti F, Raggi P, Kolodziejczak M, Buffon A, Bliden K, Tantry U, Kubica J, Sardella G, Lauten A, Agewall S, Gurbel PA, Brouwer MA.

Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):47-54. doi: 10.1093/ehjcvp/pvy038. Review.

PMID:
30247574
28.

Mortality and adverse events with brand and generic clopidogrel in the Food and Drug Administration Adverse Event Reporting System (FAERS).

Serebruany VL, Hall TS, Atar D, Agewall S, Hyun Kim M, Geudelin B, Lomakin N, Marciniak TA.

Eur Heart J Cardiovasc Pharmacother. 2018 Sep 6. doi: 10.1093/ehjcvp/pvy035. [Epub ahead of print]

PMID:
30192939
29.

Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction.

Hall TS, von Lueder TG, Zannad F, Rossignol P, Duarte K, Chouihed T, Dickstein K, Atar D, Agewall S, Girerd N; High-Risk Myocardial Infarction Database Initiative investigators.

Int J Cardiol. 2018 Dec 1;272:260-266. doi: 10.1016/j.ijcard.2018.07.137. Epub 2018 Jul 29.

PMID:
30144995
30.

Critical appraisal of the COMPASS trial.

Niessner A, Agewall S.

Eur Heart J Cardiovasc Pharmacother. 2018 Oct 1;4(4):191-192. doi: 10.1093/ehjcvp/pvy027. No abstract available.

PMID:
30113628
31.

Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review.

Vonbank A, Drexel H, Agewall S, Lewis BS, Dopheide JF, Kjeldsen K, Ceconi C, Savarese G, Rosano G, Wassmann S, Niessner A, Schmidt TA, Saely CH, Baumgartner I, Tamargo J.

Eur Heart J Cardiovasc Pharmacother. 2018 Oct 1;4(4):230-236. doi: 10.1093/ehjcvp/pvy028. Review. Erratum in: Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):36. Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):36.

PMID:
30099530
32.

New input on antiplatelet treatment and registry studies.

Agewall S.

Eur Heart J Cardiovasc Pharmacother. 2018 Jul 1;4(3):129-130. doi: 10.1093/ehjcvp/pvy016. No abstract available.

PMID:
30052852
33.

The burden of heart failure in the general population: a clearer and more concerning picture.

von Lueder TG, Agewall S.

J Thorac Dis. 2018 Jun;10(Suppl 17):S1934-S1937. doi: 10.21037/jtd.2018.04.153. No abstract available.

34.

Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis.

Deyab G, Hokstad I, Aaseth J, Småstuen MC, Whist JE, Agewall S, Lyberg T, Tveiten D, Hjeltnes G, Zibara K, Hollan I.

J Trace Elem Med Biol. 2018 Sep;49:91-97. doi: 10.1016/j.jtemb.2018.05.001. Epub 2018 May 3.

PMID:
29895378
35.

Prevalence of Anxiety and Depression Symptoms in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries.

Daniel M, Agewall S, Berglund F, Caidahl K, Collste O, Ekenbäck C, Frick M, Henareh L, Jernberg T, Malmqvist K, Schenck-Gustafsson K, Spaak J, Sundin Ö, Sörensson P, Y-Hassan S, Hofman-Bang C, Tornvall P.

Am J Med. 2018 Sep;131(9):1118-1124. doi: 10.1016/j.amjmed.2018.04.040. Epub 2018 Jun 1.

PMID:
29859805
36.

Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.

Rosano GMC, Tamargo J, Kjeldsen KP, Lainscak M, Agewall S, Anker SD, Ceconi C, Coats AJS, Drexel H, Filippatos G, Kaski JC, Lund L, Niessner A, Ponikowski P, Savarese G, Schmidt TA, Seferovic P, Wassmann S, Walther T, Lewis BS.

Eur Heart J Cardiovasc Pharmacother. 2018 Jul 1;4(3):180-188. doi: 10.1093/ehjcvp/pvy015.

PMID:
29726985
37.

Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

Aboyans V, Björck M, Brodmann M, Collet JP, Czerny M, De Carlo M, Naylor AR, Roffi M, Tendera M, Vlachopoulos C, Ricco JB, Document Reviewers, Widimsky P, Kolh P, Dick F, de Ceniga MV, Piepoli MF, Sievert H, Sulzenko J, Esc Committee For Practice Guidelines Cpg, Windecker S, Aboyans V, Agewall S, Barbato E, Bueno H, Coca A, Collet JP, Coman IM, Dean V, Delgado V, Fitzsimons D, Gaemperli O, Hindricks G, Iung B, Jüni P, Katus HA, Knuuti J, Lancellotti P, Leclercq C, McDonagh T, Piepoli MF, Ponikowski P, Richter DJ, Roffi M, Shlyakhto E, Simpson IA, Zamorano JL.

Eur J Vasc Endovasc Surg. 2018 Apr;55(4):457-464. doi: 10.1016/j.ejvs.2017.08.014. Epub 2018 Apr 6. No abstract available.

38.

Cardiovascular pharmacotherapy and real-world data.

Agewall S.

Eur Heart J Cardiovasc Pharmacother. 2018 Apr 1;4(2):65-66. doi: 10.1093/ehjcvp/pvy008. No abstract available.

PMID:
29554294
39.

[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.]

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P.

Kardiol Pol. 2018;76(2):229-313. doi: 10.5603/KP.2018.0041. Polish. No abstract available.

40.

Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP).

Dan GA, Martinez-Rubio A, Agewall S, Boriani G, Borggrefe M, Gaita F, van Gelder I, Gorenek B, Kaski JC, Kjeldsen K, Lip GYH, Merkely B, Okumura K, Piccini JP, Potpara T, Poulsen BK, Saba M, Savelieva I, Tamargo JL, Wolpert C; ESC Scientific Document Group.

Europace. 2018 May 1;20(5):731-732an. doi: 10.1093/europace/eux373. No abstract available. Erratum in: Europace. 2018 May 1;20(5):738.

PMID:
29438514
41.

Cardiovascular pharmacotherapy.

Agewall S.

Eur Heart J Cardiovasc Pharmacother. 2018 Jan 1;4(1):1. doi: 10.1093/ehjcvp/pvx036. No abstract available.

PMID:
29315398
42.

«Falskt positive troponinverdier» finnes ikke.

Atar D, Agewall S.

Tidsskr Nor Laegeforen. 2017 Dec 12;137(23-24). doi: 10.4045/tidsskr.17.0967. Print 2017 Dec 12. Norwegian. No abstract available.

PMID:
29231634
Free Article
43.

Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664].

Falk V, Baumgartner H, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, Roffi M, Alfieri O, Agewall S, Ahlsson A, Barbato E, Bueno H, Collet JP, Coman IM, Czerny M, Delgado V, Fitzsimons D, Folliguet T, Gaemperli O, Habib G, Harringer W, Haude M, Hindricks G, Katus HA, Knuuti J, Kolh P, Leclercq C, McDonagh TA, Piepoli MF, Pierard LA, Ponikowski P, Rosano GMC, Ruschitzka F, Shlyakhto E, Simpson IA, Sousa-Uva M, Stepinska J, Tarantini G, Tchétché D, Aboyans V.

Eur J Cardiothorac Surg. 2017 Oct 1;52(4):832. doi: 10.1093/ejcts/ezx363. No abstract available.

44.

Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017.

Kaluzna-Oleksy M, Aunan K, Rao-Skirbekk S, Kjellstrom T, Ezekowitz JA, Agewall S, Atar D.

Scand Cardiovasc J. 2018 Feb;52(1):1-3. doi: 10.1080/14017431.2017.1405069. Epub 2017 Dec 4. No abstract available.

PMID:
29202608
45.

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

Ibánez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P.

Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1082. doi: 10.1016/j.rec.2017.11.010. English, Spanish. No abstract available.

PMID:
29198432
46.

European Heart Journal - Cardiovascular Pharmacotherapy: A fast growing baby-filling an important gap in the literature.

Agewall S.

Eur Heart J. 2017 Nov 21;38(44):3251. doi: 10.1093/eurheartj/ehx619. No abstract available.

PMID:
29177414
47.

Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

Niessner A, Tamargo J, Koller L, Saely CH, Schmidt TA, Savarese G, Wassmann S, Rosano G, Ceconi C, Torp-Pedersen C, Kaski JC, Kjeldsen KP, Agewall S, Walther T, Drexel H, Lewis BS.

Eur Heart J. 2018 Jun 21;39(24):2274-2281. doi: 10.1093/eurheartj/ehx625. No abstract available.

PMID:
29126266
48.

Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis.

Deyab G, Hokstad I, Whist JE, Smastuen MC, Agewall S, Lyberg T, Ronda N, Mikkelsen K, Hjeltnes G, Hollan I.

Arthritis Res Ther. 2017 Oct 17;19(1):232. doi: 10.1186/s13075-017-1439-1.

49.

Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative.

Agewall S, Tjessem LH, Rossignol P, Zannad F, Atar D, Lamiral Z, Machu JL, Dickstein K, Kjekshus J, von Lueder TG, Girerd N; High Risk Myocardial Infarction Database Initiative investigators.

Int J Cardiol. 2017 Dec 15;249:274-281. doi: 10.1016/j.ijcard.2017.09.182. Epub 2017 Sep 24.

PMID:
28964557
50.

Adherence to guidelines and registry data.

Agewall S.

Eur Heart J Cardiovasc Pharmacother. 2017 Oct 1;3(4):183-184. doi: 10.1093/ehjcvp/pvx027. No abstract available.

PMID:
28922837

Supplemental Content

Loading ...
Support Center